Literature DB >> 25755697

Bone marrow-derived mesenchymal stem cells inhibits hepatocyte apoptosis after acute liver injury.

Yijing Cai1, Zhuolin Zou1, Liyuan Liu1, Si Chen1, Yi Chen1, Zhuo Lin2, Keqing Shi3, Lanman Xu3, Yongping Chen1.   

Abstract

OBJECTIVE: To investigate the protective effect of bone marrow-derived mesenchymal stem cells (BMSCs) transplantation on acute liver injury (ALI) rats.
MATERIAL AND METHODS: BMSCs were extracted from rat bone marrow, cultured and expansion in vitro, and identified by flow cytometer. Rat model with acute liver injury was established by employing D-galactosamine and Lipopolysaccharide. Male rats were randomly divided into ALI model group and BMSCs transplantation group. Rats were sacrificed 24 h, 72 h and 120 h after BMSCs injection to determine alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in serum. Proliferating cell nuclear antigen (PCNA) immunohistochemistry staining and quantitative reverse transcription polymerase chain reaction (RT-PCR) of α-fetoprotein (AFP) and glypican-3 (GPC3) were performed to analysis proliferation. Terminal deoxynucleontidyl Transferase Biotin-dUTP Nick End Labeling (TUNEL) assays were used to analyze apoptosis and mitochondria-dependent-pathway related factors Bax and Bcl-2 were examined by Western blot.
RESULTS: Compared with the ALI model group, the BMSCs transplantation group presented the lower levels of ALT, AST, decreased Bax proteins expression, and increased Bcl-2 expression. The mRNA levels of AFP and GPC3 and expression of PCNA were significantly higher in BMSCs transplantation group.
CONCLUSIONS: BMSCs transplantation could significantly restore liver function. These effects were supposed to be mediated by suppressing hepatocyte apoptosis as well as promoting proliferation. Reduction of apoptosis seemed to correlate with mitochondria-dependent-pathway.

Entities:  

Keywords:  Bone marrow-derived mesenchymal stem cells; acute liver injury; apoptosis

Mesh:

Year:  2015        PMID: 25755697      PMCID: PMC4348892     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  32 in total

1.  Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

Authors:  Marjolijn Duijvestein; Anne Christine W Vos; Helene Roelofs; Manon E Wildenberg; Barbara B Wendrich; Henricus W Verspaget; Engelina M C Kooy-Winkelaar; Frits Koning; Jaap Jan Zwaginga; Herma H Fidder; Auke P Verhaar; Willem E Fibbe; Gijs R van den Brink; Daniel W Hommes
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

2.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors:  Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

3.  The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells.

Authors:  Petar N Grozdanov; Mladen I Yovchev; Mariana D Dabeva
Journal:  Lab Invest       Date:  2006-10-02       Impact factor: 5.662

Review 4.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

Review 5.  Therapeutic plasticity of stem cells and allograft tolerance.

Authors:  Valeria Sordi; Lorenzo Piemonti
Journal:  Cytotherapy       Date:  2011-05-10       Impact factor: 5.414

6.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

Authors:  E M Horwitz; D J Prockop; L A Fitzpatrick; W W Koo; P L Gordon; M Neel; M Sussman; P Orchard; J C Marx; R E Pyeritz; M K Brenner
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

Review 7.  Recent advances in liver stem cell therapy.

Authors:  Tatiana Kisseleva; Elia Gigante; David A Brenner
Journal:  Curr Opin Gastroenterol       Date:  2010-07       Impact factor: 3.287

8.  Mesenchymal stem cells protect against neonatal rat hyperoxic lung injury.

Authors:  Hongshan Zhang; Jianpei Fang; Yanyun Wu; Yougang Mai; Wenyu Lai; Haobin Su
Journal:  Expert Opin Biol Ther       Date:  2013-03-27       Impact factor: 4.388

Review 9.  Cellular and molecular mechanisms of liver injury.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

10.  Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury.

Authors:  Angeliki Xagorari; Eleni Siotou; Minas Yiangou; Eleftheria Tsolaki; Dimitris Bougiouklis; Leonidas Sakkas; Athanassios Fassas; Achilles Anagnostopoulos
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15
View more
  16 in total

1.  Mesenchymal stem cell treatment attenuates liver and lung inflammation after ethanol intoxication and burn injury.

Authors:  Brenda J Curtis; Jill A Shults; Devin M Boe; Luis Ramirez; Elizabeth J Kovacs
Journal:  Alcohol       Date:  2018-09-11       Impact factor: 2.405

2.  Bone Marrow Mesenchymal Stem Cells Combat Lipopolysaccharide-Induced Sepsis in Rats via Amendment of P38-MAPK Signaling Cascade.

Authors:  Omnia S Zaki; Marwa M Safar; Afaf A Ain-Shoka; Laila A Rashed
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

3.  Synergistic effects of Lactobacillus rhamnosus culture supernatant and bone marrow mesenchymal stem cells on the development of alcoholic steatohepatitis in mice.

Authors:  Chao Cai; Da-Zhi Chen; Li-Chao Ge; Wen-Kai Chen; Sha-Sha Ye; Wei-Wei Ye; Ying Tao; Rui Wang; Ji Li; Zhuo Lin; Xiao-Dong Wang; Lan-Man Xu; Yong-Ping Chen
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

4.  A Novel Role of a Chemotherapeutic Agent in a Rat Model of Endotoxemia: Modulation of the STAT-3 Signaling Pathway.

Authors:  Omnia S Zaki; Marwa M Safar; Afaf A Ain-Shoka; Laila A Rashed
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

5.  Exosomes from mesenchymal stem cells induce the conversion of hepatocytes into progenitor oval cells.

Authors:  Hao-Hsiang Wu; Oscar K Lee
Journal:  Stem Cell Res Ther       Date:  2017-05-23       Impact factor: 6.832

6.  Lipopolysaccharide mediates immuno-pathological alterations in young chicken liver through TLR4 signaling.

Authors:  Xi-Yao Huang; Abdur Rahman Ansari; Hai-Bo Huang; Xing Zhao; Ning-Ya Li; Zhi-Jian Sun; Ke-Mei Peng; Juming Zhong; Hua-Zhen Liu
Journal:  BMC Immunol       Date:  2017-02-27       Impact factor: 3.615

7.  Comparison of the Treatment Efficiency of Bone Marrow-Derived Mesenchymal Stem Cell Transplantation via Tail and Portal Veins in CCl4-Induced Mouse Liver Fibrosis.

Authors:  Nhung Hai Truong; Nam Hai Nguyen; Trinh Van Le; Ngoc Bich Vu; Nghia Huynh; Thanh Van Nguyen; Huy Minh Le; Ngoc Kim Phan; Phuc Van Pham
Journal:  Stem Cells Int       Date:  2015-12-29       Impact factor: 5.443

Review 8.  Can glypican-3 be a disease-specific biomarker?

Authors:  Chaolei Chen; Xiaomin Huang; Zhaojian Ying; Dengmin Wu; Yani Yu; Xiangdong Wang; Chengshui Chen
Journal:  Clin Transl Med       Date:  2017-05-16

9.  Overexpression of c-Met in bone marrow mesenchymal stem cells improves their effectiveness in homing and repair of acute liver failure.

Authors:  Kun Wang; Yuwen Li; Tiantian Zhu; Yongting Zhang; Wenting Li; Wenyu Lin; Jun Li; Chuanlong Zhu
Journal:  Stem Cell Res Ther       Date:  2017-07-05       Impact factor: 6.832

Review 10.  Perspective of placenta derived mesenchymal stem cells in acute liver failure.

Authors:  Mahshid Saleh; Mohammad Taher; Amir Ali Sohrabpour; Amir Abbas Vaezi; Mohsen Nasiri Toosi; Maria Kavianpour; Zeinab Ghazvinian; Shahrokh Abdolahi; Javad Verdi
Journal:  Cell Biosci       Date:  2020-05-24       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.